Title
Category
Credits
Event date
Cost
  • Alzheimer Disease
  • Dementia
  • Integrated Care
  • Neuroimaging
  • Patient/Physician Communication
  • Primary Care
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Prompt treatment of early-stage Alzheimer disease (AD) can curb symptom progression. Tests for biomarkers, new symptomatic treatments and disease-modifying agents, and the addition of the preclinical stage to AD diagnostic criteria can aid in earlier disease recognition and building treatment plans.
  • Child and Adolescent Psychiatry
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Long COVID symptoms are both physical and mental in nature among children and adolescents and have the potential to affect long-term functioning and increase the overall burden on health care delivery.
  • Mood Disorders
  • Depression
  • Electroconvulsive Therapy
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
In this chart review, LGBTQ people with treatment-resistant mood disorders had clinical features linked to worse outcomes, but their improvement with ECT was similar to that seen in non-LGBTQ patients.
  • Bipolar Disorder
  • Schizophrenia/ Schizoaffective Disorders
  • Smoking
  • Substance Use Disorders
  • Suicide
  • Veterans and Military Issues
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Predicting suicide is difficult, as suicidal behavior is not linked solely to any single behavior or psychiatric diagnosis. This study compared risk of suicidal behavior among a transdiagnostic sample of Veterans with varying disorders and behaviors.
  • Primary Care
  • Patient/Physician Communication
  • Neuroimaging
  • Alzheimer Disease
  • Dementia
  • Integrated Care
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what, when to better treat your patients with AD from specialists in the field.
  • Primary Care
  • Neuroimaging
  • Alzheimer Disease
  • Dementia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Early-stage diagnosis of Alzheimer disease leads to prompt treatment initiation and better patient QoL. Learn about new guidelines and technology advances and what’s on the horizon from authorities in the field.
  • Muscular Dystrophy
  • Psychopharmacology
  • Patient/Physician Communication
  • Obsessive-Compulsive and Related Disorders
  • Violence/Aggression
  • Sleep
  • Side Effects
  • Delivery of Care
  • Cognition
  • Child and Adolescent Psychiatry
  • Depression
  • Attention-Deficit/Hyperactivity Disorder
  • Diagnostic Tools
  • Weight
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
This video reviews treatment guidelines for patients with DMD and emphasizes the importance of clinicians intervening early on behalf of individuals who develop behavioral-psychosocial comorbidities.
  • Psychotic Disorders
  • Substance Use Disorders
  • COVID-19
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Identifying risk factors that predispose individuals to negative COVID-19 outcomes is important. The current study examined the association between substance use disorders, psychiatric diagnosis, and COVID-19–related clinical outcomes.
  • Psychotic Disorders
  • Gastroenterology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
There are numerous clinical scenarios in which gastrointestinal and psychotic symptoms commonly co-occur; thus, it is important that both psychiatrists and primary care physicians have a familiarity with the differential diagnosis.
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Bipolar Disorder
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What features may predict bipolar disorder vs schizophrenia in a person with first-episode psychosis? In this journal CME activity, find out which tools could most aid diagnosis.

Pages